Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Medical University of Graz
Mayo Clinic
M.D. Anderson Cancer Center
Aveni Foundation
Servier
Centre Leon Berard
Ricoh USA, Inc.
Istituto Ortopedico Rizzoli
Quironsalud
Istituto Ortopedico Rizzoli
St. Anne's University Hospital Brno, Czech Republic
Var2 Pharmaceuticals
Abramson Cancer Center at Penn Medicine
University of Iowa
Memorial Sloan Kettering Cancer Center
UNICANCER
Hospices Civils de Lyon
Medical College of Wisconsin
Ohio State University